Investment Rating - The report maintains a moderately positive outlook for Asian equity markets, forecasting a 9% USD price return over the next 12 months with a revised MXAPJ index price target of 700, which is 3% above the previous target of 680 [3][47][54]. Core Insights - The macro risk environment has improved, with reduced US economic policy uncertainty and expectations of Fed rate cuts, which are likely to support regional equities [4][32]. - The tariff environment remains fluid, with potential impacts on GDP growth and earnings forecasts, but the overall growth impact may not be as negative as previously feared [14][19]. - Earnings growth is expected to be the dominant driver of returns, with forecasts of 9% and 10% EPS growth for 2025 and 2026, respectively [48][52]. Summary by Sections Current Conditions - The macro risk environment has improved due to moderated US economic policy uncertainty, eased financial conditions, and firm activity data, leading to a 25% rebound in the MXAPJ index [4][5][6]. Tariffs - The tariff situation is expected to influence equity performance, with potential higher rates but greater certainty. The final tariff rates may differ from current expectations, impacting GDP growth and earnings forecasts [14][15][19]. Rates - The Fed is expected to begin cutting rates in September, with a total of five cuts anticipated by mid-2026, which should support regional equities through a weaker dollar [32][33][36]. Returns - The report anticipates a wide dispersion of expected returns across markets, with a forecasted 9% USD price return over 12 months based on earnings growth and a revised index target [47][49][54]. Allocations - The report emphasizes North Asia, maintaining overweights in China, Japan, and Korea, while downgrading Malaysia to underweight. Sector upgrades include capital goods and tech hardware, while autos and consumer staples are downgraded [59][60][69][75].

Let me ask you about what the market is thinking about the budget process in the United States now, because for a long time we've talked about this and some are concerned about what this does to Medicare. I'm concerned about what this does to debt levels in the United States, importantly, from a market perspective. But is that really what is driving markets thinking right now.What are you watching as this goes once again to the House. I think that the that the interpretation from markets the moment is proba ...

Core Viewpoint - Philip Morris International has achieved a 50% total return in 2025, significantly outperforming the S&P 500 index, which remains flat this year [1]. Group 1: Business Transformation - The company has successfully pivoted from traditional cigarettes to alternative nicotine products, recognizing the global decline in cigarette usage [4]. - Philip Morris holds a dominant position in the heat-not-burn category with its Iqos brand, capturing a 77% volume share in its operating markets [4]. - In the nicotine pouch segment, the company leads with its Zyn brand, exhibiting similar market share characteristics [4]. Group 2: Financial Performance - In the last quarter, 42% of the company's revenue and 44% of gross profit were derived from smoke-free products, indicating a significant shift in its revenue composition [5]. - Overall revenue has increased to $38 billion over the last 12 months, reflecting the successful transition to alternative nicotine products [5]. Group 3: Market Conditions - The depreciation of the U.S. dollar, which has fallen from around 110 to under 100, is expected to enhance revenue in U.S. dollar terms for Philip Morris, as it primarily operates outside the U.S. [6]. - The company is positioned to benefit from this currency trend, which has contributed to the stock price increase at the start of 2025 [6]. Group 4: Traditional Tobacco Outlook - Despite the decline in cigarette usage globally, traditional tobacco products are still expected to generate cash flow for the company, particularly outside of China and the U.S. [9]. - In the last quarter, gross profit from combustibles grew by 5.3% year over year, demonstrating the continued viability of traditional tobacco in international markets [9][10]. Group 5: Valuation and Future Prospects - The stock's forward price-to-earnings (P/E) ratio has increased to 24 from 14 a year ago, and the dividend yield has decreased to 3% from nearly 6% [13]. - This rising valuation suggests that the extraordinary 50% returns may not be sustainable, but the stock remains a viable investment due to its solid dividend yield and growth potential [14]. - The combination of Iqos and Zyn growth, along with pricing power in traditional cigarettes, positions the company for potential double-digit revenue and earnings growth in the coming years [14][15].